Literature DB >> 495505

The risk of pericardiocentesis.

B Wong, J Murphy, C J Chang, K Hassenein, M Dunn.   

Abstract

The risk and potential risk factors of pericardiocentesis were assessed by a review of a series of 52 pericardiocenteses comprising all those performed in the cardiac catheterization laboratory of one institution from 1971 to 1978. On the basis of the operative results, the patients were separated into two groups for comparison; Group I comprised all patients with a successful uncomplicated (35) pericardiocentesis and Group II all those with a nonproductive (16), nontherapeutic (1) or complicated (8) pericardiocentesis. Complications consisted of one death, one cardiac arrest, one aspiration of a subdiaphragmatic abscess and five ventricular punctures without adverse sequelae. Among the patients who had a nonproductive pericardiocentesis, the condition of 11 had probably been misdiagnosed but at least 4 had a false negative pericardiocentesis. Comparison of the two groups showed no significant difference in the incidence of cardiac tamponade or in the clinical presentation based on historical, physical, electrocardiographic, roentgenographic or echocardiographic findings of pericardial disease. Pericardiocentesis was usually successful when performed for suspected malignant pericardial effusion but often unsuccessful when performed for suspected hemopericardium. Anatomically, all patients in Group II had either minimal or loculated posterior pericardial effusion. It is concluded that pericardiocentesis can be performed at a low risk that can be further minimized by consideration of the disease process and the anatomic location of the pericardial fluid.

Entities:  

Mesh:

Year:  1979        PMID: 495505     DOI: 10.1016/0002-9149(79)90176-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

1.  Large Pericardial Effusions.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-08

2.  Blind subxiphoid pericardiotomy to relieve critical acute hemopericardium: a final report.

Authors:  Y Kurimoto; K Maekawa; K Tanno; K Mori; T Koyanagi; T Ito; N Kawaharada; A Watanabe; T Higami; Y Asai
Journal:  Eur J Trauma Emerg Surg       Date:  2012-06-21       Impact factor: 3.693

Review 3.  Cardiac tamponade.

Authors:  J B Ball; W L Morrison
Journal:  Postgrad Med J       Date:  1997-03       Impact factor: 2.401

4.  Persistent ST-segment elevation following pericardiocentesis: caution with thrombolytic therapy.

Authors:  H H Hsia; N H Kander; M J Shea
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

Review 5.  Interventional Pericardiology.

Authors:  Mandeep Bhargava; Oussama M Wazni; Walid I Saliba
Journal:  Curr Cardiol Rep       Date:  2016-03       Impact factor: 2.931

6.  What is the ideal approach for emergent pericardiocentesis using point-of-care ultrasound guidance?

Authors:  Lori Stolz; Elaine Situ-LaCasse; Josie Acuña; Matthew Thompson; Nicolaus Hawbaker; Josephine Valenzuela; Uwe Stolz; Srikar Adhikari
Journal:  World J Emerg Med       Date:  2021

7.  Pericardial effusion in patients with cancer: outcome with contemporary management strategies.

Authors:  R J Laham; D J Cohen; R E Kuntz; D S Baim; B H Lorell; M Simons
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

Review 8.  Modern approaches and use of surgical treatment for pericardial disease.

Authors:  Edward P Chen; Joseph I Miller
Journal:  Curr Cardiol Rep       Date:  2002-01       Impact factor: 2.931

9.  Pericardial tamponade and large pericardial effusions: causal factors and efficacy of percutaneous catheter drainage in 50 patients.

Authors:  Mehmet Kabukcu; Fatih Demircioglu; Ekrem Yanik; Ibrahim Basarici; Filiz Ersel
Journal:  Tex Heart Inst J       Date:  2004

Review 10.  Palliative treatment of malignant pericardial effusion: report of two cases and a review of the literature.

Authors:  A Sharma; R Kamble; L Kumar; B Bhargava; B M Biswal; V Kochupillai
Journal:  Support Care Cancer       Date:  1996-07       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.